Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.
Jourdain A, Auperin A, Minard-Colin V, Aladjidi N, Zsiros J, Coze C, Gandemer V, Bertrand Y, Leverger G, Bergeron C, Michon J, Patte C; SFCE LNH Committee. Jourdain A, et al. Among authors: michon j. Haematologica. 2015 Jun;100(6):810-7. doi: 10.3324/haematol.2014.121434. Epub 2015 Feb 27. Haematologica. 2015. PMID: 25724577 Free PMC article.
Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
Rigaud C, Auperin A, Jourdain A, Haouy S, Couec ML, Aladjidi N, Gandemer V, Lambliotte A, Plat G, Landman-Parker J, Michon J, Leblanc T, Patte C, Minard-Colin V. Rigaud C, et al. Among authors: michon j. Pediatr Blood Cancer. 2019 Sep;66(9):e27873. doi: 10.1002/pbc.27873. Epub 2019 Jun 17. Pediatr Blood Cancer. 2019. PMID: 31207026 Clinical Trial.
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure.
Simonin M, Auperin A, Bertrand Y, Aladjidi N, Baruchel A, Contet A, Coze C, Gandemer V, Haouy S, Leblanc T, Leverger G, Michon J, Patte C, Minard-Colin V. Simonin M, et al. Among authors: michon j. Blood Adv. 2020 Aug 11;4(15):3621-3625. doi: 10.1182/bloodadvances.2019001398. Blood Adv. 2020. PMID: 32766852 Free PMC article. Clinical Trial.
Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.
Valteau-Couanet D, Le Deley MC, Bergeron C, Ducassou S, Michon J, Rubie H, Le Teuff G, Coze C, Plantaz D, Sirvent N, Bouzy J, Chastagner P, Hartmann O. Valteau-Couanet D, et al. Among authors: michon j. Pediatr Blood Cancer. 2014 Jun;61(6):977-81. doi: 10.1002/pbc.24713. Epub 2013 Aug 23. Pediatr Blood Cancer. 2014. PMID: 23970413 Clinical Trial.
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.
Frazer JK, Li KJ, Galardy PJ, Perkins SL, Auperin A, Anderson JR, Pinkerton R, Buxton A, Gross TG, Michon J, Leverger G, Weinstein HJ, Harrison L, Shiramizu B, Barth MJ, Goldman SC, Patte C, Cairo MS. Frazer JK, et al. Among authors: michon j. Br J Haematol. 2019 Apr;185(2):374-377. doi: 10.1111/bjh.15520. Epub 2018 Aug 16. Br J Haematol. 2019. PMID: 30117142 Free PMC article. Clinical Trial. No abstract available.
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, Weston C, Raphael M, Perkins SL, McCarthy K, Cairo MS; FAB/LMB96 International Study Committee. Patte C, et al. Among authors: michon j. Blood. 2007 Apr 1;109(7):2773-80. doi: 10.1182/blood-2006-07-036673. Blood. 2007. PMID: 17132719 Free PMC article. Clinical Trial.
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Raphaël M, Terrier-Lacombe MJ; Société Française d'Oncologie Pédiatrique. Patte C, et al. Among authors: michon j. Blood. 2001 Jun 1;97(11):3370-9. doi: 10.1182/blood.v97.11.3370. Blood. 2001. PMID: 11369626 Free article. Clinical Trial.
Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
Flandin I, Hartmann O, Michon J, Pinkerton R, Coze C, Stephan JL, Fourquet B, Valteau-Couanet D, Bergeron C, Philip T, Carrie C. Flandin I, et al. Among authors: michon j. Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1424-31. doi: 10.1016/j.ijrobp.2005.10.020. Epub 2006 Jan 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16427213
VIP hypersecretion as primary or secondary syndrome in neuroblastoma: A retrospective study by the Société Française des Cancers de l'Enfant (SFCE).
Bourdeaut F, de Carli E, Timsit S, Coze C, Chastagner P, Sarnacki S, Delattre O, Peuchmaur M, Rubie H, Michon J; Neuroblastoma Committee of the Société Française des Cancers et Leucémies de l'Enfant et de l'Adolescent. Bourdeaut F, et al. Among authors: michon j. Pediatr Blood Cancer. 2009 May;52(5):585-90. doi: 10.1002/pbc.21912. Pediatr Blood Cancer. 2009. PMID: 19143025
543 results